chromic phosphate has been researched along with Cystadenocarcinoma in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carlson, JA; Jose, B; Osborne, RP; Sharma, SC | 2 |
| Barnhill, D; Doering, D; Park, R; Proctor, J | 1 |
| Burrell, MO; Kirchner, AB; Powell, JL | 1 |
4 other study(ies) available for chromic phosphate and Cystadenocarcinoma
| Article | Year |
|---|---|
Dose estimation to the infant from breast milk following intraperitoneal administration of chromic phosphate 32P for the treatment of early ovarian cancer.
Topics: Breast Feeding; Chromium; Chromium Compounds; Cystadenocarcinoma; Female; Humans; Infant, Newborn; Milk, Human; Ovarian Neoplasms; Phosphates; Phosphorus Radioisotopes; Radiation Dosage | 1984 |
Radioactivity in breast milk after intraperitoneal chromic phosphate for the treatment of early ovarian cancer.
Topics: Adult; Breast Feeding; Chromium; Chromium Compounds; Cystadenocarcinoma; Female; Humans; Infant, Newborn; Injections, Intraperitoneal; Milk, Human; Ovarian Neoplasms; Phosphates; Phosphorus Radioisotopes; Pregnancy; Pregnancy Complications, Neoplastic | 1983 |
Bowel perforation associated with intraperitoneal chromic phosphate instillation.
Topics: Chromium; Chromium Compounds; Colonic Diseases; Cystadenocarcinoma; Female; Humans; Intestinal Perforation; Middle Aged; Ovarian Neoplasms; Phosphates | 1990 |
Intraperitoneal radioactive chromic phosphate P 32 in the treatment of ovarian cancer.
Topics: Adenocarcinoma; Brachytherapy; Chromium; Chromium Compounds; Cystadenocarcinoma; Endometriosis; Female; Humans; Middle Aged; Ovarian Neoplasms; Phosphates; Phosphorus Radioisotopes | 1987 |